Nisin variants from Streptococcus and Staphylococcus successfully express in NZ9800

Increases in antimicrobial resistance have meant that the antimicrobial potential of lantibiotics is now being investigated irrespective of the nature of the producing organism. The aim of this study was to investigate whether natural nisin variants produced by non‐Generally Recognized as Safe (GRAS) strains, such as nisin H, nisin J and nisin P, could be expressed in a well‐characterized GRAS host.

[1]  R. P. Ross,et al.  Nisin J, a Novel Natural Nisin Variant, Is Produced by Staphylococcus capitis Sourced from the Human Skin Microbiota , 2019, Journal of bacteriology.

[2]  P. Cotter,et al.  First evidence of production of the lantibiotic nisin P , 2019, Scientific Reports.

[3]  O. Kuipers,et al.  Design and Expression of Specific Hybrid Lantibiotics Active Against Pathogenic Clostridium spp. , 2019, Front. Microbiol..

[4]  R. Atun,et al.  The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study , 2019, PloS one.

[5]  S. Smits,et al.  Influence of nisin hinge-region variants on lantibiotic immunity and resistance proteins. , 2019, Bioorganic & medicinal chemistry.

[6]  S. Smits,et al.  Systematic characterization of position one variants within the lantibiotic nisin , 2019, Scientific Reports.

[7]  C. Hill,et al.  Bioengineering nisin to overcome the nisin resistance protein , 2018, Molecular microbiology.

[8]  Graham A. Hudson,et al.  RiPP antibiotics: biosynthesis and engineering potential. , 2018, Current opinion in microbiology.

[9]  A. Lewies,et al.  Antimicrobial Peptides: the Achilles’ Heel of Antibiotic Resistance? , 2018, Probiotics and Antimicrobial Proteins.

[10]  L. Dicks,et al.  Functions and emerging applications of bacteriocins. , 2018, Current opinion in biotechnology.

[11]  R. P. Ross,et al.  Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective , 2017, Front. Microbiol..

[12]  M. Rea,et al.  Controlled functional expression of the bacteriocins pediocin PA-1 and bactofencin A in Escherichia coli , 2017, Scientific Reports.

[13]  A. Hendrickx,et al.  Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies? , 2017, Trends in microbiology.

[14]  C. Kleanthous,et al.  The therapeutic potential of bacteriocins as protein antibiotics , 2017, Emerging topics in life sciences.

[15]  Xi-qiang Zhu,et al.  Effect of Co-overexpression of Nisin Key Genes on Nisin Production Improvement in Lactococcus lactis LS01 , 2017, Probiotics and Antimicrobial Proteins.

[16]  F. Bendali,et al.  Bacteriocins: Not Only Antibacterial Agents , 2016, Probiotics and Antimicrobial Proteins.

[17]  Auke J van Heel,et al.  Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery. , 2016, ACS synthetic biology.

[18]  Xiaoxuan Ge,et al.  Ligand determinants of nisin for its induction activity. , 2016, Journal of dairy science.

[19]  Xiangfang Zeng,et al.  Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal Industry , 2016, International journal of molecular sciences.

[20]  O. Kuipers,et al.  Incorporation of tryptophan analogues into the lantibiotic nisin , 2016, Amino Acids.

[21]  C. Hill,et al.  Bioengineering Lantibiotics for Therapeutic Success , 2015, Front. Microbiol..

[22]  R. P. Ross,et al.  Nisin H Is a New Nisin Variant Produced by the Gut-Derived Strain Streptococcus hyointestinalis DPC6484 , 2015, Applied and Environmental Microbiology.

[23]  R. P. Ross,et al.  Lantibiotic Resistance , 2015, Microbiology and Molecular Reviews.

[24]  Leif Smith,et al.  Biosynthesis and Transport of the Lantibiotic Mutacin 1140 Produced by Streptococcus mutans , 2015, Journal of bacteriology.

[25]  Laura J Shallcross,et al.  Antibiotic overuse: a key driver of antimicrobial resistance. , 2014, The British journal of general practice : the journal of the Royal College of General Practitioners.

[26]  Wentao Kong,et al.  Cloning and optimization of a nisin biosynthesis pathway for bacteriocin harvest. , 2014, ACS synthetic biology.

[27]  F. Hugenholtz,et al.  Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens , 2012, PloS one.

[28]  C. Hill,et al.  Bioengineering of a Nisin A‐producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z , 2011, Microbial biotechnology.

[29]  R. Rink,et al.  Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides , 2010, Antonie van Leeuwenhoek.

[30]  M. Otto.  Staphylococcus epidermidis — the 'accidental' pathogen , 2009, Nature Reviews Microbiology.

[31]  T. Walther,et al.  Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog , 2009, Journal of Pharmacology and Experimental Therapeutics.

[32]  R. P. Ross,et al.  The generation of nisin variants with enhanced activity against specific Gram‐positive pathogens , 2008, Molecular microbiology.

[33]  O. Kuipers,et al.  Dissection and Modulation of the Four Distinct Activities of Nisin by Mutagenesis of Rings A and B and by C-Terminal Truncation , 2007, Applied and Environmental Microbiology.

[34]  R. P. Ross,et al.  Food microbiology: Bacteriocins: developing innate immunity for food , 2005, Nature Reviews Microbiology.

[35]  O. Kuipers,et al.  Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin. , 2005, Biochemistry.

[36]  Michiel Kleerebezem,et al.  10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis , 2005, Applied Microbiology and Biotechnology.

[37]  M. Riley,et al.  Genetically engineered bacteriocins and their potential as the next generation of antimicrobials. , 2005, Current pharmaceutical design.

[38]  Y. Pyun,et al.  Enhanced nisin production by increasing genes involved in nisin Z biosynthesis in Lactococcus lactis subsp. lactis A164 , 2005, Biotechnology Letters.

[39]  O. Kuipers,et al.  NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated and unmodified prenisin and Fusions of the leader peptide with non-lantibiotic peptides , 2004 .

[40]  J. M. Rodríguez,et al.  Heterologous production of bacteriocins by lactic acid bacteria. , 2003, International journal of food microbiology.

[41]  D. O'sullivan,et al.  Heterologous Expression of the Lactococcus lactis Bacteriocin, Nisin, in a Dairy Enterococcus Strain , 2002, Applied and Environmental Microbiology.

[42]  R. P. Ross,et al.  Lantibiotics: structure, biosynthesis and mode of action. , 2001, FEMS microbiology reviews.

[43]  O. Kuipers,et al.  Engineering a disulfide bond and free thiols in the lantibiotic nisin Z. , 2000, European journal of biochemistry.

[44]  M. Gasson,et al.  Post-translational modification of nisin. The involvement of NisB in the dehydration process. , 1999, European journal of biochemistry.

[45]  W. D. de Vos,et al.  Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. , 1992, The Journal of biological chemistry.

[46]  C. Hill,et al.  A comparison of factors affecting the production of two bacteriocins from lactic acid bacteria , 1992 .

[47]  G. Fitzgerald,et al.  Identification of the Minimal Replicon of Lactococcus lactis subsp. lactis UC317 Plasmid pCI305 , 1990, Applied and environmental microbiology.

[48]  I. Nes,et al.  High-Frequency Transformation, by Electroporation, of Lactococcus lactis subsp. cremoris Grown with Glycine in Osmotically Stabilized Media , 1989, Applied and environmental microbiology.

[49]  L. A. Rogers,et al.  LIMITING FACTORS IN THE LACTIC FERMENTATION , 1928, Journal of bacteriology.

[50]  J. A. Majchrzykiewicz.  Bacteriocins of Streptococcus pneumoniae and its response to challenges by antimicrobial peptides , 2011 .

[51]  J. Delves-Broughton,et al.  Nisin as a food preservative , 2005 .

[52]  R. Siezen,et al.  Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. , 1993, European journal of biochemistry.

[53]  C. W. Hilbers,et al.  Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate. , 1996, European journal of biochemistry.